Showing results (221-230 of 258) with videos related to
Sort By:
Pageof 26
Diabetologia|May 9, 2006
Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesityD Boey, S Lin, T Karl, et al.The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|December 1, 1995
Protocol for ACTH administration in refractory childhood seizures: educational strategiesC O'Dell, K Maloney-Lutz, S Shinnar, et al.Journal of Clinical Neurology (Seoul, Korea)|May 30, 2015
Prevalence and Incidence of Epilepsy in an Elderly and Low-Income Population in the United StatesDerek H Tang, Daniel C Malone, Terri L Warholak, et al.Insect Biochemistry and Molecular Biology|July 10, 2004
Using RNA interference to develop dengue virus resistance in genetically modified Aedes aegyptiEmily A Travanty, Zach N Adelman, Alexander W E Franz, et al.Theranostics|May 19, 2018
Plectin-targeted liposomes enhance the therapeutic efficacy of a PARP inhibitor in the treatment of ovarian cancerSiva Sai Krishna Dasa, Galina Diakova, Ryo Suzuki, et al.Plos One|June 12, 2020
Notch3 signaling promotes tumor cell adhesion and progression in a murine epithelial ovarian cancer modelJessica C Price, Elham Azizi, L A Naiche, et al.Drugs & Aging|August 29, 2016
Anti-Dementia Drugs, Gait Performance and Mental Imagery of Gait: A Non-Randomized Open-Label TrialOlivier Beauchet, John Barden, Teresa Liu-Ambrose, et al.Maturitas|April 28, 2019
Motoric cognitive risk syndrome, incident cognitive impairment and morphological brain abnormalities: Systematic review and meta-analysisHarmehr Sekhon, Gilles Allali, Cyrille P Launay, et al.Journal of Alzheimer'S Disease : JAD|July 4, 2018
Association of Motoric Cognitive Risk Syndrome with Cardiovascular Disease and Risk Factors: Results from an Original Study and Meta-AnalysisOlivier Beauchet, Harmehr Sekhon, John Barden, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 17, 2007
A meta-analysis of the efficacy of intraperitoneal cisplatin for the front-line treatment of ovarian cancerL M Hess, M Benham-Hutchins, T J Herzog, et al.Pageof 26